
Medical device maker Enovis Corp ENOV.N down 4% at $35.76
ENOV reiterates Q1 revenue forecast to be in the range of $555 million to $563 million vs analysts' estimate of $559.6 million, according to data compiled by LSEG
Brokerage Evercore ISI analyst Vijay Kumar says shares are down partly because co reiterated Q1 forecast but did not mention forecast for the year
Separately, ENOV appoints Damien McDonald as chief executive officer effective May 12, 2025
CEO Matt Trerotola previously said in February his intention to retire
Co says Trerotola will not stand for re-election
Stock has fallen 18.6% YTD